Current State of Research About Chinese Herbal Medicines (CHM) for the Treatment of Coronavirus Disease 2019 (COVID-19): A Scoping Review
Jesús López‐Alcalde, Yuqian Yan, Claudia M. Witt, Jürgen Barth
Abstract
To the authors' knowledge, only the Chinese and the South Korean guidelines recommend CHMs as a treatment option for patients with COVID-19. These guidelines base their recommendations on the consensus of experts. Clinical guidelines or health authorities from other countries do not provide advice on CHMs. Due to the absence of RCT, there is currently no reliable evidence on the effects of any specific CHM intervention for the treatment of patients with COVID-19. A high number of clinical trials of different herbal products are being currently conducted in China.
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)Randomized controlled trialObservational studyPsychological interventionAlternative medicineMEDLINEClinical trialIntensive care medicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Narrative reviewDiseaseTraditional medicineFamily medicineInternal medicineInfectious disease (medical specialty)PathologyPsychiatryPolitical scienceLawPharmacological Effects of Natural CompoundsPlant-based Medicinal ResearchAndrographolide Research and Applications